Literature DB >> 12198613

Association between elevated neutrophil defensin levels and endometritis.

Harold C Wiesenfeld1, R Phillip Heine, Marijane A Krohn, Sharon L Hillier, Antonio A Amortegui, Michael Nicolazzo, Richard L Sweet.   

Abstract

The role of host defenses in the pathogenesis of pelvic inflammatory disease (PID) remains largely uncharacterized. The antimicrobial peptides defensins are important components of innate host defense. To explore the relationship between neutrophil defensins and upper genital tract infection, 377 women who were at risk for PID were enrolled in a study. Women infected with Neisseria gonorrhoeae, Trichomonas vaginalis, or Chlamydia trachomatis had higher median levels of neutrophil defensins (human neutrophil peptides 1-3) in the vagina than did uninfected women. Neutrophil defensins were strongly associated with the presence of endometritis after the analysis was controlled for the presence of sexually transmitted diseases. Vaginal neutrophils were associated with endometritis only in the presence of elevated defensin levels, which highlights the importance of neutrophil activation, rather than the presence of neutrophils alone, in this inflammatory process. Neutrophil defensins appear to participate in the host defense in ascending pelvic infection and the pathogenesis of PID.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198613     DOI: 10.1086/342417

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  Endogenous production of antimicrobial peptides in innate immunity and human disease.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

2.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.

Authors:  Theresa L Chang; Jesus Vargas; Armando DelPortillo; Mary E Klotman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 3.  Pathogenesis of genital tract disease due to Chlamydia trachomatis.

Authors:  Toni Darville; Thomas J Hiltke
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 4.  Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects.

Authors:  Gary A Jarvis; Theresa L Chang
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

5.  Leukotriene B(4) receptors BLT1 and BLT2 are involved in interleukin-8 production in human neutrophils induced by Trichomonas vaginalis-derived secretory products.

Authors:  Young Hee Nam; Arim Min; Seong Hoon Kim; Young Ah Lee; Kyeong Ah Kim; Kyoung-Ju Song; Myeong Heon Shin
Journal:  Inflamm Res       Date:  2012-01-04       Impact factor: 4.575

6.  Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.

Authors:  Edith Porter; Huixia Yang; Sujata Yavagal; Gloria C Preza; Omar Murillo; Heriberto Lima; Sheila Greene; Laily Mahoozi; Marcia Klein-Patel; Gill Diamond; Sunita Gulati; Tomas Ganz; Peter A Rice; Alison J Quayle
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 7.  Defensins in viral infections.

Authors:  Jian Ding; Yi-Ying Chou; Theresa L Chang
Journal:  J Innate Immun       Date:  2009-06-24       Impact factor: 7.349

8.  Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission.

Authors:  Kimyata Valere; Aprille Rapista; Eliseo Eugenin; Wuyuan Lu; Theresa L Chang
Journal:  Viral Immunol       Date:  2015-09-17       Impact factor: 2.257

Review 9.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.

Authors:  Mary E Klotman; Aprille Rapista; Natalia Teleshova; Amanda Micsenyi; Gary A Jarvis; Wuyuan Lu; Edith Porter; Theresa L Chang
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.